Clinical efficacy of (177)Lu-DOTATATE peptide receptor radionuclide therapy in thyroglobulin-elevated negative iodine scintigraphy: A “not-so-promising” result compared to GEP-NETs

This study aimed at assessing the performance of (177)Lu-DOTATATE-based peptide receptor radionuclide therapy (PRRT) in de-differentiated thyroid carcinoma thyroglobulin-elevated negative iodine scintigraphy (TENIS) in terms of clinical efficacy and outcome. This is a retrospective analysis of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Basu, Sandip, Parghane, Rahul V., Naik, Chinna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745860/
https://www.ncbi.nlm.nih.gov/pubmed/33354174
http://dx.doi.org/10.4103/wjnm.WJNM_21_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745860/
https://www.ncbi.nlm.nih.gov/pubmed/33354174
http://dx.doi.org/10.4103/wjnm.WJNM_21_19

Ejemplares similares